Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

shutterstock_158366573

Racial minority groups are not adequately represented in COVID-19 clinical studies, research argues

August 12, 2020 Research and Development COVID-19, Gilead, pharma, remdesivir

New research has warned that minority groups and people of colour are underrepresented in current trials for COVID-19 therapies, despite …
News
bristol_myers_squibb

Bristol Myers Squibb announces positive results from Opdivo clinical trials

August 12, 2020 Research and Development Bristol-Myers Squibb, Cancer, bristol myers squibb

Bristol Myers Squibb has announced positive data from two Phase 3 clinical trials of its drug Opdivo. The first trial …
News
giant-mexican-flag-waves

Mexico to hold trials for Chinese and American COVID-19 vaccines

August 12, 2020 Research and Development COVID-19, Mexico, Mexico coronavirus

Mexico aims to conduct late stage trials for coronavirus vaccines designed by US and Chinese companies. This is in hope …
News
moderna

Moderna commits 100 million COVID-19 vaccine doses to the US

August 12, 2020 Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, US, Vaccine, pharma

Moderna continues to rise to meet the demands of the pandemic, signing a new deal with the US Government to …
News
covid_cell_1_1

Pharmafile.com’s weekly COVID-19 news round-up

August 12, 2020 Research and Development COVID-19, coronavirus, covid news

The coronavirus news this week once again focuses on vaccines, as AstraZeneca signed its first deal in China to produce …
News
shutterstock_273326141

Bayer scoops up women’s healthcare biotech KaNDy Therapeutics in potential $1bn+ deal

August 11, 2020 Manufacturing and Production, Research and Development, Sales and Marketing Bayer, KaNDy Therapeutics, menopause, pharma

Bayer is set to acquire UK-based biotech KaNDy Therapeutics, assimilating the firm’s women’s healthcare development portfolio in a newly announced …
News
roche

Roche’s entrolizumab disappoints at Phase 3 in moderately to severely active ulcerative colitis

August 11, 2020 Manufacturing and Production, Research and Development Roche, etrolizumab, trial failure, ulcerative colitis

Roche has voiced its disappointment after its investigational therapy etrolizumab showed “mixed results” as a treatment for moderately to severely …
News
christine

Dr Christine Wilkinson Blanc appointed as Chief Medical Officer at Nordic Nanovector

August 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector has announced that Dr Christine Wilkinson Blanc has been appointed as the Chief Medical Officer of the company.
Appointment
novavax

Novavax inks deal to deliver one billion COVID-19 vaccine doses in India and other regions

August 10, 2020 Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, India, Novavax, Serum Institute of India Private Limited, Vaccine

Novavax is partnering up with the Serum Institute of India Private Limited (SIIPL) in a licensing deal to development and …
News
vaccination-1215279_960_720

Early promise from Novavax’s vaccine candidate for COVID-19

August 7, 2020 Medical Communications, Research and Development COVID-19, Novavax, Vaccine

New Phase 1/2 on Novavax’s COVID-19 vaccine candidate NVX‑CoV2373 has shown that the therapy generated “robust antibody responses” when used …
News
astrazeneca_plaque

AstraZeneca’s Fasenra has strong Phase 3 showing in severe eosinophilic asthma

August 6, 2020 Research and Development AstraZeneca, Fasenra, asthma

AstraZeneca took the opportunity at the American Thoracic Society 2020 Virtual International Conference to unveil positive new Phase 3b data …
News
morris

Humanigen appoints Timothy Morris as Chief Operating Officer and Chief Financial Officer

August 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Humanigen have appointed Timothy E. Morris to its newly created role of Chief Operating Officer and Chief Financial Officer and …
Appointment
nice_new_london_office_internal_3_web

NICE rejects mycosis fungoides-type cutaneous T-cell lymphoma therapy over data concerns

August 5, 2020 Research and Development, Sales and Marketing Ledaga, NICE, lymphoma

NICE has announced its rejection of Ledaga (chlormethine gel), a topical therapy for the treatment of mycosis fungoides-type cutaneous T-cell …
News
800px-nhs_nnuh_entrance

NICE advises GPs to stop prescribing opioids for chronic pain

August 5, 2020 Business Services, Research and Development COVID-19, coronavirus

The National Institutes of Health and Care Excellence has released its first guideline on the treatment of chronic pain and …
News

EMA expands label for UCB’s Cimzia in axial spondyloarthritis

August 5, 2020 Research and Development, Sales and Marketing Cimzia, EMA, Europe

The European Medicines Agency has expanded the existing approval of UCB’s Cimzia (certolizumab pegol) to cover the treatment of axial …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026